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Bioengineered cardiac tissues represent a promising strategy for regenerative medicine. However,
methods of vascularization and suitable cell sources for tissue engineering and regenerative medicine
have not yet been established. In this study, we developed methods for the induction of vascular
endothelial cells from mouse embryonic stem (ES) cells using three-dimensional (3D) suspension cul-
ture, and fabricated cardiac cell sheets with a pre-vascularized structure by co-culture of mouse ES cell-
derived endothelial cells. After induction, isolated CD31þ cells expressed several endothelial cell marker
genes and exhibited the ability to form vascular network structures similar to CD31þ cells from neonatal
mouse heart. Co-culture of ES cell-derived CD31þ cells with ES cell-derived cardiomyocytes and dermal
ﬁbroblasts resulted in the formation of cardiac cell sheets with microvascular network formation. In
contrast, microvascular network formation was reduced in co-cultures without cardiomyocytes, sug-
gesting that cardiomyocytes within the cell sheet might enhance vascular endothelial cell sprouting.
Polymerase chain reaction array analysis revealed that the expression levels of several angiogenesis-
related genes, including ﬁbroblast growth factor 1 (FGF1), were up-regulated in co-culture with car-
diomyocytes compared with cultures without cardiomyocytes. The microvascular network in the cardiac
sheets was attenuated by treatment with anti-FGF1 antibody. These results indicate that 3D suspension
culture methods may be used to prepare functional vascular endothelial cells from mouse ES cells, and
that cardiomyocyte-mediated paracrine effects might be important for fabricating pre-vascularized
cardiac cell sheets.
© 2015, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Well-organized, functional tissues are composed of various cell
types. Tissue engineering represents a new therapeutic approach
for the treatment of congenital defects and functional disorders,
and methods for constructing 3D functional tissues are therefore
required. We previously developed cell-sheet engineering that
allowed the creation of functional 3D tissues by layering two-
dimensional conﬂuent cell sheets harvested from temperature-
responsive culture surfaces [1e4]. A well-organized vascular
network is essential for metabolic exchange throughout the engi-
neered 3D tissues. In the case of neonatal rat cardiac cell sheets,
CD31þ cells formed a network structure connecting host and graft
vessels upon in vivo transplantation [5,6]. Furthermore, large
numbers of cells are needed to fabricate functional 3D tissues.
Embryonic stem (ES) cells and induced pluripotent stem (iPS) cells
are considered as likely sources of cells for regenerative medicine.sting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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ES cells in large-scale suspension cultures, and recently reported
the creation of cardiac cell sheets by co-culture with car-
diomyocytes derived from mouse ES cells and cardiac ﬁbroblasts
[7,8]. Large-scale differentiation systems were also applicable for
the collection of cardiomyocytes and formation of cardiac cell
sheets from human iPS cells [9].
Several studies have reported the induction of cardiovascular
cells from pluripotent stem cells [10e12]. Yamashita et al. reported
that cardiovascular cells could be differentiated frommouse ES and
iPS cells throughmesodermal progenitor fatal liver kinase 1 (Flk1)þ
cells [13e15], and administration of vascular endothelial growth
factor (VEGF) and cAMP resulted in the effective induction of
arterial endothelial cells by activation of Notch signaling [16]. Pre-
vascularization of cardiac cell sheets is important for prompt
microvascular communication between transplanted grafts and
host tissue, leading to better engraftment upon transplantation.
Although cardiac cell sheets have been prepared from car-
diomyocytes, endothelial cells, and mural cells derived frommouse
ES or iPS cells [17,18], microvascular network formation in vitro has
not been clear. Several issues regarding the use of pluripotent stem
cell-derived endothelial cells for the fabrication of bioengineered
cardiac tissue remain to be resolved, including: (1) genetic and
functional differences in endothelial cells derived from heart tissue
and pluripotent stem cells; (2) the contribution of pluripotent stem
cell-derived endothelial cells to the microvascular network in vitro;
and (3) the molecular mechanism underlying endothelial cell
microvascular network formation in cardiac cell sheets.
With the aim of reconstructing ES cell-derived well-vascular-
ized 3D cardiac tissues, we induced CD31þ cells from mouse ES
cells using spinner ﬂask cultures and generated cardiac cell sheets
with a microvascular network structure by co-culturing CD31þ
cells with mouse ES cell-derived cardiomyocytes and dermal
ﬁbroblasts.2. Methods
2.1. Animals
Wild-type C57BL/6 mice were purchased from Japan SLC (Shi-
zuoka, Japan). Animal experiments were approved by the Institu-
tional Animal Care and Use Committee of Tokyo Women's Medical
University.2.2. Antibodies
Biotin-conjugated monoclonal antibodies for murine Flk1
(eBioscience, San Diego, CA, USA) and murine CD31 (BD Bio-
sciences, San Jose, CA, USA) were used as primary antibodies for
magnetic-activated cell sorting (MACS) separation. Phycoerythrin-
conjugated monoclonal antibody for murine vascular endothelial
(VE)-cadherin (BioLegend, San Diego, CA, USA) and monoclonal
antibodies for cardiac troponin T (Thermo Fisher Scientiﬁc, Wal-
tham, MA, USA), murine CD31, endothelial nitric oxide synthase
(eNOS; BD Biosciences), murine a-smooth muscle actin (SMA;
SigmaeAldrich, St. Louis, MO) and collagen type IV alpha 3 (Col4a3;
kindly provided by Dr. Sado, Shigei Medical Research Institute,
Japan) were used as primary antibodies for immunocytochemistry.
Antibodies for SM22a (Abcam, Cambridge, MA, USA) and ﬁbroblast
growth factor (FGF) 1 (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) were also used as primary antibodies for immunocytochem-
istry. Anti-mouse, anti-rat, or anti-rabbit IgG antibodies conjugated
with Alexa488, Alexa568 or Cy5 (Molecular Probes, Eugene, OR,
USA) were used as secondary antibodies for immunocytochemistry.2.3. ES cell culture
R1 ES cells expressing the neomycin phosphotransferase gene
under the control of the a-myosin heavy chain promoter (R1-neo)
[19] with the enhanced yellow ﬂuorescent protein (EYFP) gene (R1-
neo EYFP) [20] weremaintained on 1% gelatin-coated tissue culture
dishes in Dulbecco's modiﬁed Eagle's medium supplemented with
5% fetal bovine serum, 2 mM L-glutamine, 0.1 mM 2-
mercaptoethanol, 0.1 mM non-essential amino acids (NEAA),
1 mM sodium pyruvate, 1% penicillin/streptomycin and 1000 U/ml
leukemia inhibitory factor (LIF).
EMG7 ES cells expressing the enhanced green ﬂuorescent pro-
tein gene under the control of the a-myosin heavy chain promoter
[15] were maintained in Glasgow's minimum essential medium
supplemented with 10% fetal bovine serum, 0.1 mM 2-
mercaptoethanol, 0.1 mM NEAA, 1 mM sodium pyruvate, 1% peni-
cillin/streptomycin and 1000 U/ml LIF.
2.4. Preparation of cardiac cells
ES cell-derived cardiomyocytes were prepared by neomycin
selection of differentiated R1 ES cells, as described previously [7]
with a few modiﬁcations. To induce differentiation, R1 ES cells
were cultured in the presence of noggin (150 ng/ml) (R&D Systems,
Minneapolis, MN, USA) from day 3 to day 1 of induction of dif-
ferentiation. The differentiation medium for R1 ES cells was Dul-
becco's modiﬁed Eagle's medium supplemented with 15% fetal
bovine serum, 2 mM L-glutamine, 0.1 mM 2-mercaptoethanol,
0.1 mM NEAA, 1 mM sodium pyruvate and 1% penicillin/strepto-
mycin. Trypsinized R1 ES cells were seeded at 5  104 cells/ml
(total, 200 ml/ﬂask) into spinner ﬂasks and cultured in the absence
of LIF until day 18. On day 5, the volume of medium was increased
to 400 ml/ﬂask. Granulocyte colony-stimulating factor (1 ng/ml)
was added to the differentiation medium from day 5 to day 10, and
fetal bovine serum in the differentiationmediumwas replacedwith
bovine serum from day 7 to day 18. For selection of ES cell-derived
cardiomyocytes, differentiated cells were cultured in the presence
of G418 from days 10 to 18. On day 18, undifferentiated cells
included in the suspension culture were depleted by MACS using
anti SSEA-1 microbeads.
2.5. Preparation of CD31þ cells
CD31þ cells were prepared from differentiated EMG7 or R1-neo
EYFP ES cells. To induce differentiation, trypsinized ES cells were
seeded at 1  105 cells/ml into spinner ﬂasks and cultured in the
absence of LIF until day 5. Differentiationmedium for EMG7 ES cells
consisted of MEM-a supplemented with 10% fetal bovine serum,
0.05 mM 2-mercaptoethanol and 1% penicillin/streptomycin. Dif-
ferentiation medium for R1-neo EYFP ES cells consisted of Dul-
becco's modiﬁed Eagle's medium supplemented with 15% fetal
bovine serum, 2 mM L-glutamine, 0.1 mM 2-mercaptoethanol,
0.1 mM NEAA, 1 mM sodium pyruvate and 1% penicillin/strepto-
mycin. On day 5, embryoid bodies were enzymatically dissociated
and subjected to MACS to separate Flk1þ cells. Flk1þ cells were re-
culturedwith both VEGF (50 ng/ml) and 8-bromo-cAMP (0.5mmol/
l) onto collagen IV-coated tissue culture dishes. Three days after re-
culture, induced CD31þ cells were isolated from re-cultured Flk1þ
cells by MACS.
2.6. Mouse primary cell culture
Dermal ﬁbroblasts were obtained from young adult mice.
Dermal tissue specimens were cut into pieces 1 cm2 and incubated
at 4 C for 24 h with 500 U/ml dispase. The skin was separated into
S. Masuda et al. / Regenerative Therapy 2 (2015) 6e168dermal and epidermal layers and the dermis were placed on the
surface of 100 mm culture dishes and minced into 1 mm2 squares.
After adherence of the minced dermal tissue, Dulbecco's modiﬁed
Eagle's medium supplemented with 10% fetal bovine serum and 1%
penicillin/streptomycin was gently added to the culture dishes and
the cells were maintained at 5% CO2 at 37 C.
Cardiomyocytes and cardiac ﬁbroblasts were obtained from the
heart of neonatal mice (1e2 days old) as described previously [7].
CD31þ cells were prepared from the fraction of cardiomyocytes by
MACS using CD31 antibody.
2.7. Immunocytochemistry
Cells were ﬁxed with 5% dimethyl sulfoxide in methanol and
blocked with 1% skimmed milk. The ﬁxed cells were stained with
primary antibody overnight at 4 C, followed by incubation with
secondary antibody for 3 h at 4 C. Nuclei were visualized with
Hoechst 33342.
2.8. High-throughput image acquisition and data analysis
Images of CD31þ cell network structures were collected using
ImageXpress Ultra confocal high content screening system (Mo-
lecular Devices, LLC, Sunnyvale, CA, USA). The computer systemsFig. 1. Scheme for induction of cardiovascular differentiation from mouse ES cells. Mouse E
differentiation, R1-neo ES cells were cultured in the presence of noggin and granulocyte col
presence of G418 to select cardiomyocytes. (B) For CD31þ cell differentiation, embryoid bodi
5. Flk1þ cells were plated onto collagen IV-coated tissue culture dishes and cultured in th
culture, CD31þ cells were isolated from re-cultured Flk1þ cells by MACS.and hardware were operated by MetaXpress software (Molecular
Devices, LLC). The ‘Z series’ acquisition function was used to
construct the best-focus images. Twenty sequential images (each
10 mmdepth) were acquired along the Z axis. Sequential acquisition
of images was performed automatically at each wavelength. The
tube length and tube thickness of CD31þ cells were scored using
MetaXpress software (Molecular Devices, LLC). The acquired im-
ages were analyzed automatically using the ‘Journal’ function. Im-
ages highlighted with Alexa568 (CD31þ cells) were processed with
the morphology ﬁlter to eliminate the effect of non-speciﬁc stain-
ing. CD31þ cell network structures were detected using the
‘Angiogenesis’ and ‘Neurite Outgrowth’ application modules, and
the tube length and tube thickness of CD31þ cells were scored in
the overlapping region detected by the above two modules.2.9. Cell-sheet manipulation
Cell sheets were harvested by simple pipetting, as described by
Haraguchi et al. [3]. Brieﬂy, intact cell sheets were detached by
transferring conﬂuent cells cultured on a temperature-responsive
culture surface to an incubator at 20 C for 30 min. The detached
cell sheet was spread on the surface by aspirating and incubated at
37 C for 1 h to adhere to the culture surface.S cells were cultured in spinner ﬂasks for cardiovascular differentiation. (A) For cardiac
ony-stimulating factor. From day 10 to day 18, differentiated cells were cultured in the
es were dissociated enzymatically and subjected to MACS to separate Flk1þ cells on day
e presence of VEGF and 8-bromo-cAMP for further differentiation. After 3 days of re-
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Total RNAwas extracted from cells using an RNeasy PlusMini Kit
(Qiagen, Hilden, Germany), according to manufacturer's in-
structions. First-strand synthesis was performed on a T3000
ThermoCycler (Biometra) using a RT2 First Strand Kit (Qiagen). The
cDNA was mixed with RT2 SYBR Green ROX qPCR Mastermix
(Qiagen) and added to each well of the Mouse Angiogenesis RT2
Proﬁler PCR Array (Qiagen). Polymerase chain reaction (PCR) was
performed using a StepOnePlus system (ABI), following the man-
ufacturer's protocol. Data were analyzed by the comparative CT
method with glucuronidase, beta (Gusb) as a housekeeping gene.Fig. 2. ES cell-derived CD31þ cells were positive for endothelial markers. After 5 days of diff
tissue culture dishes with VEGF and 8-bromo-cAMP for further differentiation. After 3 day
tibodies. (A) Immunostaining for CD31 (red) and mural cell markers (SMA, SM22a; green).
(green), and (D) for CD31 (green) and VE-cadherin (red). (E) Relative expression of endoth
primary cultures. Nuclei were stained with Hoechst 33342 (blue). Scale bars ¼ 400 mm (C an2.11. Quantitative real-time PCR
First strand cDNA was synthesized using a High Capacity cDNA
Reverse Transcription Kit (ABI) from puriﬁed total RNA isolated
using an RNeasy Plus Mini Kit (Qiagen). First-strand synthesis was
performed on a T3000 ThermoCycler (Biometra). Quantitative real-
time (qRT)-PCR was carried out using a StepOnePlus system (ABI),
according to the manufacturer's instructions. The expression levels
of genes for activin receptor like 1 (Acvrl1), cadherin 5 (CDH5),
chemokine receptor type 4 (Cxcr4), delta-like ligand 4 (Dll4),
ephrin-B2 (Efnb2), ephrin type-B receptor 4 (Ephb4), fms-related
tyrosine kinase 1 (Flt1), kinase insert domain receptor (KDR),erentiation, Flk1þ cells were isolated by MACS and re-cultured onto collagen IV-coated
s of Flk1þ cell differentiation, induced cells were immunostained with respective an-
(B) Numbers of Flk1þ and CD31þ cells. (C) Immunostaining for CD31 (red) and eNOS
elial marker genes in CD31þ cells derived from both mouse ES cells and mouse heart
d D). Values are shown as mean ± standard deviation for three separate experiments.
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Fig. 3. (continued).
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member 2 (Nr2f2), platelet/endothelial adhesion molecule 1
(Pecam1) and POU class 5 homeobox 1 (Pou5f1) were analyzed by
TaqMan gene expression assay (ABI) and gene expression was
normalized to endogenous b-actin. Col4a3, chemokine (C-X-C
motif) ligand 5 (Cxcl5), epidermal growth factor (Egf), Fgf1, midkine
(Mdk), transforming growth factor-a (Tgfa) and thymidine phos-
phorylase (Tymp) were also analyzed by TaqMan gene expression
assay, and normalized to endogenous Gusb.
2.12. Statistical analysis
Data are presented as means ± standard deviation. Student's t-
tests or paired t-tests were used to analyze differences between
two groups, as appropriate. Data for multiple groups were
compared by TukeyeKramer multiple comparison tests. Differ-
ences were considered signiﬁcant when P < 0.05.
3. Results
3.1. Scalable endothelial cell differentiation of mouse ES cells
Differentiation of EMG7 ES cells was induced by seeding at
1  105 cells/ml into spinner ﬂasks (Fig. 1). After 5 days of differ-
entiation in spinner ﬂasks, embryoid bodies were dissociated and
Flk1þ cells were isolated by MACS. Flk1þ cells were plated onto
collagen IV-coated tissue culture dishes with VEGF and 8-bromo-
cAMP for further differentiation. After 3 days of re-culture, induced
CD31þ cells and SMAþ cells were conﬁrmed by immunocyto-
chemistry (Fig. 2A). The number of isolated Flk1þ cells was about
1.0  107 ± 5.01  106 cells (100% of the initial ES cell number) and
1.16  107 ± 4.86  106 CD31þ cells were obtained from 1  107
Flk1þ cells (116% of the initial ES cell number) (Fig. 2B). Nearly all
the CD31þ cells were positive for other endothelial markers,
including VE-cadherin and eNOS, and negative for smooth muscleFig. 3. ES cell-derived CD31þ cells formed vascular network structures in co-culture with E
CD31þ network structure derived from mouse EMG7 ES cells (ES-CD31þ) and neonatal m
cardiomyocytes and mouse dermal ﬁbroblasts. Cardiac troponin T (cTnT) (red) and CD31 (
4. (D) R1-neo EYFP ES cell-derived CD31þ cell network structure in co-culture with R1-neo E
stained with Hoechst 33342 (blue). Immunostaining for CD31þ cells in (B) and (D) was ana
bars ¼ 400 mm in (B) and (D). Values are shown as mean ± standard deviation for three se
Immunostaining of cardiac cell sheet with CD31þ cell network structure. After non-invasi
formed well-established network structures throughout the cardiac cell sheet at day 4. CD31
panel is magniﬁed as right panel. Scale bars ¼ 2 mm in left panel and 400 mm in right pancell markers such as SMA and SM22a (Fig. 2A, CeE). CD31þ VE-
cadherinþ cells were also collected from R-1 neo EYFP mouse ES
cells through same procedure (data not shown). qRT-PCR analysis
revealed that expression of endothelial marker genes in R-1 neo
EYFP ES cell-derived CD31þ cells was higher than in undifferenti-
ated R-1 neo EYFP cells, and similar to that in CD31þ cells from
primary heart cells (Fig. 2E). These results suggest that 3D-sus-
pension culture might be useful for collecting large numbers of
CD31þ endothelial cells from mouse ES cells.3.2. ES cell-derived CD31þ cells form vascular network structures
We compared the abilities of ES cell-derived CD31þ cells (ES-
CD31þ) and CD31þ cells from neonatal mouse heart (nmh-CD31þ)
to form network structures when mixed with ES cell-derived car-
diomyocytes and mouse dermal ﬁbroblasts at ratios of 1:12:3 and
seeded at 3.2  105 cells/cm2 (Fig. 3A). After 4 days of culture, the
formation of a CD31þ endothelial cell network structure was
observed (Fig. 3B). Tube length and tube thickness of the endo-
thelial cell network in ES-CD31þ co-cultures were similar to those
in neonatal mouse heart CD31þ co-cultures (tube length, ES-
CD31þ co-culture: 6.02 ± 0.87  105 mm; nmh-CD31þ co-culture:
7.56 ± 0.86  105 mm; tube thickness, ES-CD31þ co-culture:
11.67 ± 1.44 mm; nmh-CD31þ co-culture: 10.50 ± 0.76 mm) (Fig. 3C).
These results indicate that ES cell-derived endothelial cells had the
ability to form vascular network structures in co-culture with car-
diac cells, and there was no notable difference between endothelial
cells derived from ES cells and those from neonatal mouse heart.
We examined the effect of the number of endothelial cells on
vascular network formation. When R1-neo EYFP ES cell-derived
endothelial cells were co-cultured with R1-neo ES cell-derived
cardiomyocytes and mouse dermal ﬁbroblasts, the tube length in
the resulting endothelial network structure increased with
increasing endothelial cell number (Fig. 3D). In contrast, there wereS cell-derived cardiomyocytes and ﬁbroblasts. (A) Schematic diagram of co-culture. (B)
ouse heart (nmh-CD31þ) after 4 days in co-culture with R1-neo EYFP ES cell-derived
green). (C) Analysis of CD31þ cell network structures within co-cultured cells at day
S cell-derived cardiomyocytes and mouse dermal ﬁbroblasts. CD31 (green). Nuclei were
lyzed using MetaXpress software. Tube length and tube thickness are indicated. Scale
parate experiments in (C) and six separate experiments in (D). NS, not signiﬁcant. (E)
ve harvesting of cell sheets using temperature-responsive culture dishes, CD31þ cells
þ cells were derived from R1-neo EYFP ES cells. cTnT (red), CD31 (green). Square in left
el.
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Fig. 4. (continued).
S. Masuda et al. / Regenerative Therapy 2 (2015) 6e16 13no signiﬁcant associations between tube thickness and other con-
ditions independent of endothelial cell density in the co-culture.
Cardiac cell sheets with an endothelial cell network structure
were fabricated by co-culturing R1-neo ES cell-derived car-
diomyocytes, mouse dermal ﬁbroblasts, and R1-neo EYFP ES cell-
derived endothelial cells on fetal bovine serum-coated 24-well
temperature-responsive culture plates. After 4 days of co-culture,
the co-cultured cells were detached as intact cell sheets at 20 C
within 1 h. Endothelial cell network structures were maintained
throughout the cardiac cell sheet (Fig. 3E).
3.3. Involvement of cardiomyocyte-derived FGF1 in the formation of
endothelial cell network structure
Endothelial cell network structures were formed by co-culture
of R1-neo ES cell-derived cardiomyocytes (C), R1-neo EYFP ESFig. 4. ES cell-derived cardiomyocytes had a positive effect on the formation of CD31þ cell ne
formed in co-culture with R1-neo ES cell-derived cardiomyocytes, R1-neo EYFP ES cell-deri
structure was observed when R1-neo ES cell-derived cardiomyocytes were depleted from th
Comparison of CD31þ cell network structure formation between C þ E þ F and E þ F. Tube len
with conditioned medium from co-cultures containing ES cell-derived cardiomyocytes (C
diomyocyte density on formation of CD31þ cell network. Tube length and tube thickness are
fold) in C þ E þ F compared with E þ F by RT2 Proﬁler PCR Array. Gene expression levels in C
and R1-neo EYFP ES cell-derived CD31þ cells (E) were analyzed and the gene expression rat
(C þ E þ F), cells were immunostained with respective antibodies for cTnT (green) and FG
network formation by neutralizing FGF1 antibody. Nuclei were stained with Hoechst 33342
bars ¼ 400 mm in (B) and (E) and 200 mm in (G). Values are shown as mean ± standard de
separate experiments in (E) and (F), and six separate experiments in (H). *P < 0.05, **P < 0cell-derived endothelial cells (E), and mouse dermal ﬁbroblasts (F)
(Fig. 4A; Cþ Eþ F, panels B, C). In contrast, endothelial cell network
structures were reduced in the absence of R1-neo ES cell-derived
cardiomyocytes (Fig. 4A; E þ F, panels B, C). The endothelial cell
network structure was mostly rescued when ES cell-derived
endothelial cells and ﬁbroblasts were co-cultured with condi-
tioned medium from C þ F (Fig. 4A; C þ F, panel D). Tube lengths in
the endothelial cell network structure increased with increasing
density of ES cell-derived cardiomyocytes within the co-culture,
though tube thickness remained largely unchanged (Fig. 4E).
These results imply that soluble factor(s) derived from ES cell-
derived cardiomyocytes might contribute to the formation of the
CD31þ cell network structure in co-culture. To identify the key
factor(s), the expression levels of 84 key angiogenesis-related genes
were examined in C þ E þ F and E þ F by RT2 Proﬁler PCR Array
(Qiagen). The gene expression levels of Col4a3, Cxcl5, Egf, Fgf1,twork structure. (A) Schematic diagram of co-culture. (B) CD31þ cell network structure
ved CD31þ cells, and mouse dermal ﬁbroblasts (C þ E þ F). Little CD31þ cell network
e co-culture (E þ F). CD31 (green), nuclei were stained with Hoechst 33342 (blue). (C)
gth and tube thickness are indicated. (D) CD31þ cell network structure formed in E þ F
þ F). Tube length and tube thickness are indicated. (E) Effect of ES cell-derived car-
indicated. (F) Real-time PCR analyses of six genes demonstrated higher expression (>5-
þ E þ F, E þ F, R1-neo ES cell-derived cardiomyocytes (C), mouse dermal ﬁbroblasts (D),
ios for C þ E þ F, C, E, and F relative to E þ F are indicated. (G) After 4 days of co-culture
F1 (red). Nuclei were stained with Hoechst 33342 (blue). (H) Inhibition of CD31þ cell
(blue). Tube length and tube thickness were calculated from CD31þ cell staining. Scale
viation for eight separate experiments in (C), four separate experiments in (D), three
.01. NS, not signiﬁcant.
S. Masuda et al. / Regenerative Therapy 2 (2015) 6e1614Mdk, Tgfa and Tymp in Cþ Eþ F was >5-fold that in Eþ F (Table 1).
qRT-PCR conﬁrmed that Col4a3, Fgf1 and Mdk gene expression
levels were signiﬁcantly higher in C þ E þ F compared with E þ F,
while differences in Cxcl5, Egf, Tgfa and Tymp were not signiﬁcant.
Col4a3 and Fgf1 were predominantly expressed in cardiomyocytes,
while Mdk was expressed in cardiomyocytes and endothelial cells.
Furthermore, Mdk expression in endothelial cells was higher than
in cardiomyocytes. Consistent with the modest endothelial
network formation in E þ F, Mdk might not be important for
cardiomyocyte-mediated endothelial network formation.
We also examined the protein expression levels of FGF1 and
Col4a3 in cardiomyocytes. As shown in Fig. 4G, FGF1, but not Col4a3
(data not shown), was expressed in ES cell-derived cardiomyocytes.
We ﬁnally elucidated the contribution of FGF1 to endothelial
network formation in C þ E þ F cultures using anti-FGF1 neutral-
izing antibody (Fig. 4H). Tube length, but not tube thickness, was
signiﬁcantly reduced in endothelial cells co-cultured with car-
diomyocytes and ﬁbroblasts in the presence of anti-FGF1 antibody.
These ﬁndings suggest that cardiomyocytes might promote endo-
thelial network formation in bioengineered cardiac tissue via
secreted FGF-1.
4. Discussion
The results of the present study provide the ﬁrst evidence to
support the use of a 3D-suspension culture system for collecting
Flk1þ mesodermal progenitor cells and CD31þ endothelial cells
from mouse ES cells. ES cell-derived CD31þ endothelial cells were
identical to CD31þ endothelial cells from neonatal mouse heart in
terms of gene expression and network formation. The potential of
3D tissue for regenerative medicine has been extensively reported.
We previously reported on the fabrication of 3D cardiac tissue with
microvascular networks by layering cardiac cell sheets from
neonatal rat hearts containing endothelial cells on various types of
vascular beds [21e23]. Furthermore, several reports have indicated
the importance of endothelial cells for fabricating 3D tissues,
including liver and cartilage [24,25]. However, the generation of
sufﬁcient numbers of endothelial cells is a prerequisite for further
advances in functional regenerative medicine. Cardiovascular cells
including cardiomyocytes, endothelial cells, and mural cells have
been shown to differentiate from mesodermal progenitor Flk1þ
cells in two-dimensional culture [14,15]. The addition of 8-bromo-
cAMP and VEGF promoted the differentiation of CXCR4þ arterial
endothelial cells from Flk1þ cells via activation of Notch signaling
[16]. We recently reported the importance of 3D-suspension cul-
ture for collecting sufﬁcient numbers of cardiomyocytes from
mouse ES cells and human iPS cells for the fabrication of bio-
engineered cardiac tissue. In the current study, mouse ES cells were
cultured in spinner ﬂasks to induce Flk1þ cells. Around 1  107
Flk1þ cells were isolated after 5 days in culture, and the cell
number was identical to the starting cell number. After a further 3Table 1
Angiogenesis-related gene expression calculated
by PCR array analysis. The genes, which expressed
in Cþ Eþ F co-culture higher more than 5 fold than
that in E þ F co-culture, were indicated.
Gene symbol Fold
Fgf1 93.5
Col4a3 24.62
Mdk 10.81
Tgfa 8.61
Tymp 6.37
Cxcl5 5.57
Egf 5.55days culture on collagen-coated dishes, we were able to collect
around 1  107 CD31þ endothelial cells. These ﬁnding suggest that
scalable cultures using 3D-suspension systems may produce large
numbers of endothelial cells.
Understanding the differences in gene expression and function
between endothelial cells derived from ES cells and hearts is a
prerequisite for fabricating bioengineered vascularized tissue. In
this study, CD31þ cells derived from both EMG7 and R1-neo EYFP
ES cells were positive for both VE-cadherin and eNOS and
demonstrated the ability to form CD31þ cell network structures.
qRT-PCR analysis found no notable difference between CD31þ cells
derived from ES cells and CD31þ cells from heart tissue in the
expression patterns of vascular endothelial genes. In addition to
artery genes such as Acvrl1, CXCR4, Dll4, and ephrin B2, the venous
endothelial cell marker Nr2f2 was highly expressed in ES cell-
derived CD31þ cells. Although Notch signaling and Nr2f2 are
crucial for specifying arterial and venous differentiation, cell fate in
terms of artery versus vein is relatively plastic in immature endo-
thelial cells [26] and the fate of ES cell-derived CD31þ cells might
not be decided because of their immaturity. Both CD31þ cells
derived from ES cells and CD31þ cells from heart tissues formed
microvascular network when co-cultured with ES cell-derived
cardiomyocytes and dermal ﬁbroblasts. Images of network struc-
tures of CD31þ cells were collected and calculated the length and
thickness of tube structures. ‘Tube length’ is an index of the length
of tube structure formed of CD31þ cells, and the value of CD31þ
cells derived from ES cells was almost equal to that of CD31þ cells
from heart tissues. It is thought that sprouting activity of these
CD31þ cells in co-culture were identical. In addition, both of the
value of ‘tube thickness’, an index of the diameter of tube structure
formed of CD31þ cells, were similar to that of capillary, approxi-
mately 10 mm, and characteristic endothelial cobblestone structure
in 2D culture was not observed in both CD31þ cells in co-culture.
These ﬁndings suggest that ES cell-derived endothelial cells
display a similar phenotype to endothelial cells from heart tissue,
and may thus be useful for fabricating vascularized bioengineered
cardiac tissue.
We fabricated cardiac cell sheets using dermal ﬁbroblasts as
stromal cells and produced endothelial microvascular networks. In
contrast however, Masumoto et al. fabricated cardiac cell sheets in
ES cell-derived cardiomyocyte, endothelial cell, and mural cell co-
cultures, but endothelial cells were spottily distributed and little
network formation was observed after 4 days in culture [17]. This
apparent discrepancy in terms of microvascular network formation
might be associated with differences in cellular components. One
possible mechanism for the inhibitory effect of mural cells on
endothelial cell network formation might be their ability to stabi-
lize vascular structures. Sphingosine-1-phosphate-induced release
of tissue inhibitor of metalloproteinase 2 (TIMP2) from vascular
smooth muscle cells inhibits angiogenesis [27]. In contrast, ﬁbro-
blasts play important roles in promoting angiogenesis through the
secretion of growth factors and production of extracellular matrix
molecules [28,29]. Furthermore, we previously reported that the
pre-vascular structure of human aortic endothelial cells was
created by sandwiching them between human dermal ﬁbroblast
sheets [30]. These observations suggest that the behavior of CD31þ
cells might depend on the types of co-cultured cells, and ﬁbroblasts
might have supportive effects on the formation of endothelial cell
network structures.
Cardiomyocytes are indispensable for endothelial cell micro-
vascular network formation. Accordingly, co-culture of endothelial
cells with dermal ﬁbroblasts without cardiomyocytes resulted in
little microvascular network formation. Cardiomyocytes secrete
abundant FGF1, and treatment with anti-FGF1 antibody inhibited
microvascular network formation, suggesting that cardiomyocytes
S. Masuda et al. / Regenerative Therapy 2 (2015) 6e16 15might promote endothelial cell network formation in cardiac cell
sheets through paracrine effects. FGF1 is a well-known growth
factor involved in many biological processes, including cell prolif-
eration, differentiation, migration, and angiogenesis [31]. In this
study, treatment with anti-FGF1 antibody resulted in the reduction
of the value of tube length, but not tube thickness, suggesting that
cardiomyocyte-derived FGF1 might promote endothelial cell
sprouting in the co-culture. Among several signaling modules
related to FGF1, the Akt signaling pathway is implicated in FGF1-
induced angiogenesis in vivo [32]. Transgenic FGF1 over-
expression in myocardial tissue resulted in increased density and
branching of coronary arteries [33], and new vessels were formed
in ischemic human heart after injection of human recombinant
FGF1 [34]. Cardiomyocytes have recently been reported to function
as angiogenic cells in development and diseases. Cardiomyocyte-
derived angiopoietin 1 plays a crucial role in coronary vein for-
mation in the developing heart [35]. Cyclic mechanical stretching
promotes VEGF expression in adult cardiomyocytes through NF kB
activation [36] with increasing capillary density during the early
stage of heart hypertrophy, via HIF-1-mediated VEGF up-regulation
[37]. Indeed, PCR array analysis indicated up-regulation of several
angiogenic factors, such as VEGF and Ang-1, in Cþ Eþ F co-cultures.
The present study focused on genes that were up-regulated5-fold
in C þ E þ F compared with E þ F, but we cannot exclude the
possibility that VEGF and Ang-1 may also contribute to
cardiomyocyte-mediated endothelial cell network formation.
In conclusion, we developed a scalable suspension culture
method for the differentiation of endothelial cells from mouse ES
cells. ES cell-derived endothelial cells formed network structures
within cardiac cell sheets, and ES cell-derived cardiomyocytes
contributed to the formation of these networks via FGF1 expres-
sion. The development of a scalable strategy for generating and
collecting human endothelial cells, and a better understanding of
the molecular mechanisms of pre-vascularization in human bio-
engineered cardiac tissue, will enable us to fabricate functional 3D
tissues for regenerative medicine and tissue models.
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